DNA RNA and Cells

04 Dec 2016 Alnylam Reports Positive Interim Phase 1 Results for Fitusiran in Hemophilia A and B Patients with Inhibitors
04 Dec 2016 Juno Therapeutics Announces Complete Response and Corresponding Early Survival Data for JCAR014 in Patients with Ibrutinib-Refractory CLL
04 Dec 2016 Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL
01 Dec 2016 Sorrento's TNK Therapeutics Provides Progress Update for its Anti-CD38 and CD123 CAR-T Programs for Treatment of Hematological Malignancies
01 Dec 2016 bluebird bio Announces Interim Phase 1 Dose Escalation Data for its Anti-BCMA CAR T Product Candidate in Patients with Relapsed/Refractory Multiple Myeloma
30 Nov 2016 Arrowhead Pharmaceuticals Focuses Resources on Subcutaneous and Extra-Hepatic RNAi Therapeutics
29 Nov 2016 VBL Therapeutics Announces Overall Survival Data for VB-111 Monotherapy in Phase 2 Study for Recurrent Thyroid Cancer
29 Nov 2016 Gemphire Therapeutics Enrolls First Patients in the ROYAL-1 Trial Investigating Gemcabene in Hypercholesterolemia
23 Nov 2016 Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical Hold
23 Nov 2016 NantKwest Announces Landmark Study Published on high affinity haNK Cell Therapy in the Journal Oncotarget
22 Nov 2016 Tocagen Presents Updated Clinical and Preclinical Data at Scientific Meetings
22 Nov 2016 Clinical and Pre-Clinical Data on Mustang Bio’s MB-101 (IL13Rα2-specific CAR T cells) for the Treatment of Glioblastoma (GBM) Presented at the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology
22 Nov 2016 Viralytics’ CAVATAK in Combination with KEYTRUDA Provides Promising Results in Advanced Melanoma from the CAPRA 1b study
21 Nov 2016 Celyad Announces the Approval to Initiate Its NKR-2 CAR-T Clinical Trial in Belgium
17 Nov 2016 ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer
16 Nov 2016 Agilis Biotherapeutics Announces First Patient Treated in Phase IIb Clinical Study of Gene Therapy for AADC Deficiency
16 Nov 2016 Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate: UCART123
16 Nov 2016 Medigene highlights a new approach for neoantigen-specific TCRs at Neoantigen Summit 2016 in Boston
15 Nov 2016 The Medicines Company and Alnylam Pharmaceuticals Present Positive Results from ORION-1 Phase 2 Study of Inclisiran (formerly PCSK9si)
15 Nov 2016 Sleeping Beauty System Used to Co-express CAR with Membrane-Bound IL-15 to Enhance Persistence of CD19-Specific T Cells
15 Nov 2016 Ionis Pharmaceuticals Reports Positive Clinical Data from IONIS-ANGPTL3-L Rx
15 Nov 2016 Arrowhead Pharmaceuticals Presents New Data on ARC-F12 and ARC-LPA Using DPCsqTM Subcutaneous RNAi Delivery Vehicle
15 Nov 2016 NantKwest Announces Achievement of End Point in Merkel Cell Carcinoma Phase II Trial With Evidence of Efficacy of Activated Natural Killer (aNK) Cells in Solid Tumors
14 Nov 2016 Arrowhead Pharmaceuticals Presents New Data on ARC-AAT
14 Nov 2016 Alnylam Pharmaceuticals Announces Sanofi Genzyme Opt-in Decision for Co-Development and Co-Commercialization of Fitusiran in Hemophilia and Rare Bleeding Disorders

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing